BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34023340)

  • 1. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations.
    Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF
    Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
    Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
    Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
    Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
    Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
    Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
    Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase gene mutations (MODY 2) in Asian Indians.
    Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
    Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
    Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
    Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.
    Steele AM; Shields BM; Wensley KJ; Colclough K; Ellard S; Hattersley AT
    JAMA; 2014 Jan; 311(3):279-86. PubMed ID: 24430320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
    Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
    Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features.
    Hughes AE; De Franco E; Globa E; Zelinska N; Hilgard D; Sifianou P; Hattersley AT; Flanagan SE
    Pediatr Diabetes; 2021 Sep; 22(6):876-881. PubMed ID: 34085361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).
    Cuesta-Muñoz AL; Tuomi T; Cobo-Vuilleumier N; Koskela H; Odili S; Stride A; Buettger C; Otonkoski T; Froguel P; Grimsby J; Garcia-Gimeno M; Matschinsky FM
    Diabetes Care; 2010 Feb; 33(2):290-2. PubMed ID: 19903754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.